All Articles

Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance

Histone deacetylases in the regulation of cell death and survival mechanisms in resistant BRAF-mutant cancers

Optimizing therapeutic approaches for HR+/HER2- advanced breast cancer: clinical perspectives on biomarkers and treatment strategies post-CDK4/6 inhibitor progression

Regulatory role of non-coding RNAs in 5-Fluorouracil resistance in gastrointestinal cancers

Integrative multi-omics analysis for identifying novel therapeutic targets and predicting immunotherapy efficacy in lung adenocarcinoma

Cancer-associated fibroblast-derived extracellular vesicles: regulators and therapeutic targets in the tumor microenvironment

Ferroptosis-related signaling pathways in cancer drug resistance

Mechanisms of immunotherapy resistance in small cell lung cancer

Mitochondrial genome variability and metabolic alterations reveal new biomarkers of resistance in testicular germ cell tumors

Ovarian tumor microenvironment contributes to tumor progression and chemoresistance

Role of the TME in immune checkpoint blockade resistance of non-small cell lung cancer

CIRCUS: CIRCUlating tumour cells in soft tissue Sarcoma - a short report

Overcoming drug resistance through extracellular vesicle-based drug delivery system in cancer treatment

The emerging role of GLP-1 receptor agonists in treating or preventing cancer

Breast cancer cell resistance to hormonal and targeted therapeutics is correlated with the inactivation of the NR6A1 axis

Mechanism of ferroptosis resistance in cancer cells

HDAC-driven mechanisms in anticancer resistance: epigenetics and beyond

Reprogrammed lipid metabolism in advanced resistant cancers: an upcoming therapeutic opportunity